News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kramer Robert
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/06/2023 |
4
| Kramer Robert (President and CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 19,231 shares
@ $0
Granted 38,462 shares
@ $0
Granted 38,462 options to buy
@ $12.06, valued at
$463.9k
|
|
| 03/02/2023 |
4
| Kramer Robert (President and CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 3,226 shares
@ $12.38, valued at
$39.9k
|
|
| 02/27/2023 |
4
| Kramer Robert (President and CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 1,428 shares
@ $14.3, valued at
$20.4k
Paid exercise price by delivering 1,591 shares
@ $13.71, valued at
$21.8k
|
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2019 |
4
| Kramer Robert (President and CEO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 95 shares
@ $47.49, valued at
$4.5k
|
|
| 02/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/10/2018 |
4
| Kramer Robert (President and COO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 647 shares
@ $0
Granted 646 shares
@ $0
Granted 2,586 options to buy
@ $48.33, valued at
$125k
|
|
| 03/13/2018 |
4
| Kramer Robert (EVP, Administration and CFO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 1,727 shares
@ $51.84, valued at
$89.5k
|
|
| 03/01/2018 |
4
| Kramer Robert (EVP, Administration and CFO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 5,917 shares
@ $0
Paid exercise price by delivering 778 shares
@ $49.64, valued at
$38.6k
Paid exercise price by delivering 1,545 shares
@ $49.97, valued at
$77.2k
Granted 23,670 options to buy
@ $49.64, valued at
$1.2M
|
|
| 03/10/2017 |
4
| Kramer Robert (EVP, Corproate Services Div) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 1,908 shares
@ $30.98, valued at
$59.1k
Paid exercise price by delivering 3,007 shares
@ $31.05, valued at
$93.4k
|
|
| 03/02/2017 |
4
| Kramer Robert (EVP, Corproate Services Div) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Acquired 1,672 shares
@ $0
Acquired 1,061 shares
@ $0
Acquired 1,425 shares
@ $0
Granted 8,161 shares
@ $0
Granted 8,162 shares
@ $0
Paid exercise price by delivering 1,799 shares
@ $30.63, valued at
$55.1k
Acquired 1,672 options to buy
@ $25.62, valued at
$42.8k
Acquired 2,121 options to buy
@ $26.45, valued at
$56.1k
Acquired 2,847 options to buy
@ $30.86, valued at
$87.9k
Granted 32,638 options to buy
@ $30.63, valued at
$999.7k
|
|
| 02/24/2017 |
4/A
| Kramer Robert (EVP, Corporate Services Divisi) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Sold 11,531 shares
@ $35.49, valued at
$409.2k
Sold 3,939 shares
@ $35.74, valued at
$140.8k
Sold 17,354 shares
@ $35.48, valued at
$615.7k
Sold 5,503 shares
@ $35.66, valued at
$196.2k
Sold 445 shares
@ $35.93, valued at
$16k
Sold 1,855 shares
@ $35.8, valued at
$66.4k
Sold 2,945 shares
@ $35.73, valued at
$105.2k
Exercised 11,531 options to buy
@ $14.41, valued at
$166.2k
Exercised 3,939 options to buy
@ $14.67, valued at
$57.8k
Exercised 17,354 options to buy
@ $28.09, valued at
$487.5k
Exercised 5,503 options to buy
@ $29, valued at
$159.6k
|
|
| 07/15/2016 |
3
| Kramer Robert (President) has filed a Form 3 on Aptevo Therapeutics Inc. |
| 04/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/05/2016 |
4
| Kramer Robert (EVP, Corporate Services Divisi) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Sold 5,766 shares
@ $36.9, valued at
$212.8k
Sold 1,970 shares
@ $36.9, valued at
$72.7k
Sold 8,677 shares
@ $36.9, valued at
$320.2k
Sold 2,752 shares
@ $36.9, valued at
$101.5k
Sold 2,623 shares
@ $36.9, valued at
$96.8k
Paid exercise price by delivering 422 shares
@ $34.22, valued at
$14.4k
Exercised 5,766 options to buy
@ $14.41, valued at
$83.1k
Exercised 1,970 options to buy
@ $14.67, valued at
$28.9k
Exercised 8,677 options to buy
@ $28.09, valued at
$243.7k
Exercised 2,752 options to buy
@ $29, valued at
$79.8k
|
|
| 04/05/2016 |
4
| Kramer Robert (EVP, Corporate Services Divisi) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Sold 11,531 shares
@ $35.49, valued at
$409.2k
Sold 3,939 shares
@ $35.74, valued at
$140.8k
Sold 17,354 shares
@ $35.48, valued at
$615.7k
Sold 5,503 shares
@ $35.66, valued at
$196.2k
Sold 445 shares
@ $35.93, valued at
$16k
Sold 1,855 shares
@ $35.8, valued at
$66.4k
Sold 2,945 shares
@ $35.73, valued at
$105.2k
Exercised 11,531 options to buy
@ $14.41, valued at
$166.2k
Exercised 3,939 options to buy
@ $14.67, valued at
$57.8k
Exercised 17,354 options to buy
@ $28.09, valued at
$487.5k
Exercised 5,503 options to buy
@ $29, valued at
$159.6k
|
|
| 03/11/2016 |
4
| Kramer Robert (EVP, Corporate Services Div) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 1,796 shares
@ $34.6, valued at
$62.1k
Paid exercise price by delivering 2,786 shares
@ $34.38, valued at
$95.8k
|
|
| 03/03/2016 |
4
| Kramer Robert (EVP, Corporate Services Divisi) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 14,780 shares
@ $0
Granted 29,550 options to buy
@ $33.83, valued at
$999.7k
|
|
| 11/06/2013 |
4
| Kramer Robert (CFO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 1,219 shares
@ $19.58, valued at
$23.9k
|
|
| 06/04/2013 |
4
| Kramer Robert (CFO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Acquired 58,249 shares
@ $0 |
|
| 03/12/2013 |
4
| Kramer Robert (CFO) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 3,940 shares
@ $0
Granted 7,879 options to buy
@ $14.67, valued at
$115.6k
|
|
| 10/05/2012 |
4
| Kramer Robert (EVP Corporate Svs. Div) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Paid exercise price by delivering 290 shares
@ $14.79, valued at
$4.3k
|
|
| 08/14/2012 |
4
| Kramer Robert (consultant) has filed a Form 4 on Emergent BioSolutions Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
|
|